Rebamipide: evidence base for use in gastroenterology

Abstract

Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.

Keywords

• rebamipide
• gastroesophageal reflux disease
• corrosive esophagitis
• functional dyspepsia
• chronic gastritis
• peptic ulcer disease
• helicobacter pylori
• nsaid gastropathy
• nsaid enteropathy
• ulcerative colitis